The fellowship program involves a series of didactic classes designed to provide basic skills in clinical design, pharmacokinetics and pharmacogenetics, biomarker assessment and development, as well as ethical issues in clinical research. Didactic courses take place within a rich academic research environment that involves the study of therapeutics in humans of all ages and ethnicities.
Aug. 7, 2026
Drug Metabolism Overview
Zeruesenay Desta, PhD
Aug. 14, 2026
Clinical Relevance of CYP2Cs Genetic Polymorphism Part 1
Zeruesenay Desta, PhD
Aug. 21, 2026
Clinical Relevance of CYP2Cs Genetic Polymorphism Part 2
Zeruesenay Desta, PhD
Aug. 28, 2026
Pharmacogenetics of Phase II Metabolism: Glucuronidation and Thiopurine Methyltransferase
Zeruesenay Desta, PhD
Sept. 4, 2026
Pharmacogenetics: General Concepts
Todd Skaar, PhD
Sept. 11, 2026
Genotyping and Sequencing I
Todd Skaar, PhD
Sept. 18, 2026
Clinical Pharmacogenomics Testing
Victoria Pratt, PhD, FACMG
Sept. 25, 2026
PGx Extraction
Tyler Shugg, PharmD, PhD
Oct. 2, 2026
Genotyping and Sequencing I
Todd Skaar, PhD
Oct.9, 2026
Pharmacogenetics of CYP2D6
Todd Skaar, PhD
Oct. 16, 2026
Pharmacogenomics of Drug Transporters and Pharmacogenomics of Hypertension Therapies
Michael Eadon, MD
Oct. 23, 2026
Clinical Implementation of Pharmacogenomic Testing
Emma Tillman, PharmD, PhD
Oct. 30, 2026
Phenoconversions
Tom Callaghan, MD, PhD
Nov. 6, 2026
GWAS, Polygenic Models, and Secondary Big Data Analysis
Tyler Shugg, PharmD, PhD
Nov. 13, 2026
Opioid Pharmacodynamics
Tom Callaghan, MD, PhD
Nov. 20, 2026
Pharmacogenetics of CYP3A
Todd Skaar, PhD
Nov. 27, 2026
No Didactics - Day after Thanksgiving
Dec. 4, 2026
Cancer Somatic Genomics
Patrick Kiel, PharmD
Dec. 11, 2026
QT Prolongation
Brian Overholser, PharmD, FDCP
March 13, 2026
Statistical Analysis 1: Continuous Data
Forrest Williamson, PhD, MS
March 20, 2026
Statistical Analysis 2: Categorical Data
Forrest Williamson, PhD, MS
March 27, 2026
No Class
April 3, 2026
Statistical Tests and Model Building
Paul Berg, MS
April 10, 2026
Human Studies 1 (Design)
Forrest Williamson, PhD, MS
April 17, 2026
Human Studies 2 (Analysis/Interpretations)
Forrest Williamson, PhD, MS
April 24, 2026
Statistical Methods for Clinical Pharmacology
Forrest Williamson, PhD, MS
August 29, 2025
Drug Measurement 2 -- macromolecular drugs
Ronald Bowsher, PhD
September 5, 2025
Drug Measurement 1 -- small molecules
Lais Da Silva, PhD
September 19, 2025
Kinetics Following and Intravenous Bolus Dose
Richard Bergstrom, PhD and Lais Da Silva, PhD
September 26, 2025
Membranes and Distribution
Lais Da Silva, PhD
October 3, 2025
Elimination
Steve Hall, PhD
October 10, 2025
Constant Rate Input
Rich Bergstrom, PhD
October 17, 2025
Kinetics Following an Extravascular Dose
Kevin Sowinski, PhD
October 24, 2025
Absorption
Lais Da Silva, PhD
October 31, 2025
Response Following a Single Dose; Therapeutic Window
Brian Overholser, PharmD
November 7, 2025
Multiple Dose Regimens; Initiating and Managing Therapy
Rich Bergstrom, PhD
November 14, 2025
Variability; Genetics; Drug Interactions
Sara Quinney, PharmD, PhD
November 21, 2025
Age, Weight, and Gender; Disease
Sara Quinney, PharmD, PhD
December 5, 2025
Metabolite and Drug Response
Steve Hall, PhD
December 12, 2025
Distribution Kinetics
Sara Quinney, PharmD, PhD
March 14, 2025
Toxicology
Thomas Jones, PhD
March 21, 2025
NO DIDACTICS - 14th Annual Indiana CTSI Pharmacometrics Modeling and Simulation Symposium
March 28, 2025
Introduction/Phase I
Eric A. Benson, MD, PhD
April 4, 2025
NO DIDACTICS
April 11, 2025
Biomarker Development
Tom Callaghan, MD, PhD
April 18, 2025
Precision Oncology Trials
William Macais, MD, PhD
April 25, 2025
Role of Modeling
Robert Stratford, PhD
May 2, 2025
Preclinical Pharmacology
Sitta Sittampalam, PhD
May 9, 2025
Special Populations: Gender, Disease, Age, and Other Covariates
Rich Bergstrom, PhD
May 16, 2025
Special Populations: Hepatic/Renal Impaired States
Michael Eadon, MD
May 23, 2025
Ethical Considerations and Rate Diseases
Matt Rotelli, PhD
May 30, 2025
Late Phase Trial Development
William Macias, MD, PhD
Aug. 9, 2024
Pharmacogenetics: General Concepts
Todd Skaar, PhD
Aug. 16, 2024
Genotyping and Sequencing I
Todd Skaar, PhD
Aug. 23, 2024
Genotyping and Sequencing II
Todd Skaar, PhD
Aug. 30, 2024
Drug Metabolism Overview
Zeruesenay Desta, PhD
Sept. 6, 2024
Clinical Relevance of CYP2Cs Genetic Polymorphism Part 1
Zeruesenay Desta, PhD
Sept. 13, 2024
Clinical Relevance of CYP2Cs Genetic Polymorphism Part 2
Zeruesenay Desta, PhD
Sept. 20, 2024
Clinical Pharmacogenomics Testing
Victoria Pratt, PhD, FACMG
Sept. 27, 2024
Pharmacogenetics of Phase II Metabolism: Glucuronidation and Thiopurine Methyltransferase #2
Zeruesenay Desta, PhD
Oct. 4, 2024
Pharmacogenetics of CYP2D6
Todd Skaar, PhD
Oct. 11, 2024
Pharmacogenetics of CYP3A
Todd Skaar, PhD
Oct. 18, 2024
Pharmacogenomics of Drug Transporters and Pharmacogenomics of Hypertension Therapies
Michael Eadon, MD
Oct. 25, 2024
PGx Extraction
Tyler Shugg, PharmD, PhD
Nov. 1, 2024
Phenoconversions
Tom Callaghan, MD, PhD
Nov. 8, 2024
GWAS, Polygenic Models, and Secondary Big Data Analysis
Nick Powell, PharmD
Nov. 15, 2024
Opioid Pharmacodynamics
Tom Callaghan, MD, PhD
Nov. 22, 2024
Clinical Implementation of Pharmacogenomic Testing
Emma Tillman, PharmD, PhD
Nov. 29, 2024
No Didactics - Day after Thanksgiving
Dec. 6, 2024
Cancer Somatic Genomics
Patrick Kiel, PharmD
Dec. 13, 2024
QT Prolongation
Brian Overholser, PharmD, FDCP